AETHLON MEDICAL, INC. Earnings Per Share, Basic and Diluted
AETHLON MEDICAL, INC. (AEMD) reported Earnings Per Share, Basic and Diluted of -$0.16 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-14
- AETHLON MEDICAL, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.16.
- AETHLON MEDICAL, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.13.
- AETHLON MEDICAL, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.16.
- AETHLON MEDICAL, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.20.
- AETHLON MEDICAL, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.65.
- AETHLON MEDICAL, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.87.
- AETHLON MEDICAL, INC. earnings per share, basic and diluted for fiscal 2019 was -$5.13.
- AETHLON MEDICAL, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.10.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.16 10-Q · filed 2022-02-14 | -$0.29 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.46 10-Q · filed 2022-02-14 | |||||
| 2021-09-30 | -$0.13 10-Q · filed 2021-11-09 | -$0.29 10-Q · filed 2021-11-09 | ||||||
| 2021-06-30 | -$0.16 10-Q · filed 2021-08-09 | |||||||
| 2021-03-31 | -$0.65 10-K · filed 2021-06-24 | |||||||
| 2020-12-31 | -$0.20 10-Q · filed 2022-02-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2022-02-14 | -$0.50 10-Q · filed 2022-02-14 | |||||
| 2020-09-30 | -$0.15 10-Q · filed 2021-11-09 | -$0.29 10-Q · filed 2021-11-09 | ||||||
| 2020-06-30 | -$0.15 10-Q · filed 2021-08-09 | |||||||
| 2020-03-31 | -$1.87 10-K · filed 2021-06-24 | |||||||
| 2019-12-31 | -$0.28 10-Q · filed 2021-02-10 | -$1.20 derived: net income ÷ weighted average shares · filed 2021-02-10 | -$2.52 10-Q · filed 2021-02-10 | |||||
| 2019-09-30 | -$1.29 10-Q · filed 2020-10-28 | -$2.91 10-Q · filed 2020-10-28 | ||||||
| 2019-06-30 | -$1.63 10-Q · filed 2020-08-11 | -$0.11 10-Q · filed 2019-08-14 | ||||||
| 2019-03-31 | -$5.13 10-K · filed 2020-06-25 | -$0.07 10-K · filed 2019-07-01 | ||||||
| 2018-12-31 | -$1.67 10-Q · filed 2020-02-10 | -$0.11 10-Q · filed 2019-02-11 | -$3.82 10-Q · filed 2020-02-10 | -$0.25 10-Q · filed 2019-02-11 | ||||
| 2018-09-30 | -$1.17 10-Q · filed 2019-11-01 | -$0.08 10-Q · filed 2018-11-06 | -$2.14 10-Q · filed 2019-11-01 | -$0.14 10-Q · filed 2018-11-06 | ||||
| 2018-06-30 | -$0.06 10-Q · filed 2019-08-14 | |||||||
| 2018-03-31 | -$0.10 10-K · filed 2019-07-01 | -$0.46 10-K · filed 2018-06-08 | ||||||
| 2017-12-31 | -$0.08 10-Q · filed 2019-02-11 | -$0.40 10-Q · filed 2019-02-11 | ||||||
| 2017-09-30 | -$0.14 10-Q · filed 2018-11-06 | -$0.35 10-Q · filed 2018-11-06 | ||||||
| 2017-06-30 | -$0.21 10-Q · filed 2018-08-08 | |||||||
| 2017-03-31 | -$0.94 10-K · filed 2018-06-08 | |||||||
| 2016-12-31 | -$0.15 10-Q · filed 2018-02-01 | -$0.72 10-Q · filed 2018-02-01 | ||||||
| 2016-09-30 | -$0.29 10-Q · filed 2017-11-02 | -$0.57 10-Q · filed 2017-11-02 | ||||||
| 2016-06-30 | -$0.28 10-Q · filed 2017-08-10 | |||||||
| 2016-03-31 | -$0.66 10-K · filed 2017-06-28 | |||||||
| 2015-12-31 | -$0.16 10-Q · filed 2017-02-10 | -$0.50 10-Q · filed 2017-02-10 | ||||||
| 2015-09-30 | -$0.16 10-Q · filed 2016-11-10 | -$0.34 10-Q · filed 2016-11-10 | ||||||
| 2015-06-30 | -$0.18 10-Q · filed 2016-08-11 | |||||||
| 2015-03-31 | -$1.22 10-K · filed 2016-06-29 | |||||||
| 2014-12-31 | -$0.26 10-Q · filed 2016-02-04 | -$0.01 10-Q · filed 2015-02-10 | -$1.12 10-Q · filed 2016-02-04 | -$0.02 10-Q · filed 2015-02-10 | ||||
| 2014-09-30 | -$0.16 10-Q · filed 2015-11-16 | $0.00 10-Q · filed 2014-11-10 | -$0.92 10-Q · filed 2015-11-16 | -$0.02 10-Q · filed 2014-11-10 | ||||
| 2014-06-30 | -$0.80 10-Q · filed 2015-08-13 | -$0.02 10-Q · filed 2014-08-14 | ||||||
| 2014-03-31 | -$3.44 10-K · filed 2015-07-13 | -$0.07 10-K · filed 2014-07-15 | ||||||
| 2013-12-31 | -$0.01 10-Q · filed 2015-02-10 | -$0.03 10-Q · filed 2015-02-10 | ||||||
| 2013-09-30 | -$0.02 10-Q · filed 2014-11-10 | -$0.02 10-Q · filed 2014-11-10 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | |||||||
| 2013-03-31 | -$0.03 10-K · filed 2014-07-15 | |||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-11 | -$0.01 10-Q · filed 2014-02-11 | ||||||
| 2012-09-30 | -$0.01 10-Q · filed 2013-11-14 | -$0.02 10-Q · filed 2013-11-14 | ||||||
| 2012-06-30 | -$0.01 10-Q · filed 2013-08-13 | |||||||
| 2012-03-31 | -$0.08 10-K · filed 2013-07-15 | |||||||
| 2011-12-31 | -$0.01 10-Q · filed 2013-02-12 | -$0.04 10-Q · filed 2013-02-12 | ||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 | -$0.03 10-Q · filed 2012-11-13 | ||||||
| 2011-06-30 | -$0.03 10-Q/A · filed 2012-08-28 | |||||||
| 2011-03-31 | -$0.08 10-K · filed 2012-06-29 | |||||||
| 2010-12-31 | -$0.03 10-Q · filed 2012-02-16 | -$0.12 10-Q · filed 2012-02-16 | ||||||
| 2010-09-30 | -$0.04 10-Q · filed 2011-11-18 | -$0.09 10-Q · filed 2011-11-18 | ||||||
| 2010-06-30 | -$0.05 10-Q/A · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |